|
|
|
Real Estate News Releases
|
(EMAILWIRE.COM, November 03, 2009 ) Windsor, Ontario - FreeHotPennyStocks.com, an online financial publication, provides investors timely stock market alerts. If you are interested in penny stocks that are poised to breakout sign up for our free penny stock newsletter. Each day we send out alerts on different hot penny stocks. For more FREE ALERTS SIGN UP AT http://www.freehotpennystocks.com
Total Nutraceutical Solutions, Inc. (TNUS) announced Sunday evening that the company has started evaluating several proprietary mushroom compounds for activity in controlling the development of AlzheimerÂ’s Disease (AD). TNS was informed by Model Biosystems, Inc. (MBS), San Clemente, CA, that a recent experiment in Drosophila melanogaster flies (Drosophila) showed that certain TNS proprietary mushrooms had unusual anti-inflammatory activity. MBS was of the opinion that TNS should evaluate these mushroom samples in a special MBS biologic model for AlzheimerÂ’s disease (AD). This proprietary AD model uses a genetic mutant of Drosophila that was developed in the laboratory of Dr. Krishna Bhat, University of Texas, Galveston, Texas. This unique live model system can evaluate the activity of a given compound/ingredient in controlling biologic reactions and compounds that are associated with the development of human AD. The organic whole food mushrooms developed by TNS are being studied, pursuant to a signed research agreement, dated Friday, October 30, 2009, in a double-blinded investigator protocol; the total study will involve over 1,000 Drosophila with 120 organisms in each test group.
“The discovery and development of organic whole foods that positively impact or help prevent diseases are welcome breakthroughs in healthcare, as more and more people demand natural alternatives to prevent disease,” stated Marvin S. Hausman MD, CEO, TNS. “We believe that the unique, proprietary technology developed by TNS and used in the production of our natural organic specialty mushrooms, contributes significantly to the potential success of this new Alzheimer’s disease study to be undertaken by TNS and MBS.”
“I am pleased that MBS is able to offer TNS the services of our biotechnology testing in their research and development of natural organic mushrooms for alternative medical approaches to preventing human diseases,” stated Malli Varanasi, President, MBS. “Alzheimer’s disease is a terrible human affliction and new preventative measures would be well-received by all people.”
The company previously close at $1.22 in the last trading session. The company hit a new 52 week high of $1.31 in heavy trading before selling off.
About Freehotpennystocks.com
Freehotpennystocks.com alerts its members on any stocks from penny stocks to NYSE stocks. Our penny stock forum offers free penny stock trading videos, trading software and broker reviews to our members. Our investing forum has discussions on hot penny stocks to long term investments. All the penny stocks that we alert on have above average trading volume, strong news and penny stocks that are moving to the upside quickly. Our penny stock newsletter is great for investors who are starting in the stock market and want a place for information. If you are interest in seeing hot penny stocks and want free penny stock picks come visit freehotpennystocks.com for a free membership. We also track small cap companies and other stocks that may be positioned to break out. Free Hot Penny Stocks is not a registered investment advisor or broker-dealer. Please do your own Due Diligence before investing in any of the stocks mentioned above.
Please click here to read the full disclaimer at http://www.freehotpennystocks.com/disclaimer.html
Resultz Media
Michael Ryan
877-301-9737
staff@freehotpennystocks.com 
|
|
|
|
Real Estate News by Sector
|
|
|
|
|
